Biolife Solutions (BLFS) Income from Discontinued Operations (2023 - 2024)
Biolife Solutions' (BLFS) quarterly Income from Discontinued Operations came in at 298000.0 in Q4 2024, down 26.27% year-on-year from 404183.91 in Q1 2024, and down 673.08% on a QoQ basis from 52000.0 in Q3 2024.
Biolife Solutions (BLFS) Income from Discontinued Operations (2023 - 2024) Analysis & Trends
Biolife Solutions (BLFS) has 2 years of Income from Discontinued Operations data on file, last reported at 298000.0 in Q4 2024.
- On a quarterly basis, Income from Discontinued Operations fell 26.27% year-over-year to 298000.0 in Q4 2024; TTM through Sep 2025 was 298000.0, a 325.71% decrease from a year earlier, with the FY2024 full-year figure at 132000.0, up 43.35% from the prior year.
- Income from Discontinued Operations for Q4 2024 stood at 298000.0, down from 52000.0 in the prior quarter.
- Over the last five years, Income from Discontinued Operations for BLFS reached as high as 114000.0 in Q1 2024 and fell as low as 298000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.01 Bn | 120.80 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 44.76 Bn | 43.95 Bn | 2.15 Bn | - |
| 3 | Alcon | 33.14 Bn | 31.48 Bn | 1.53 Bn | - |
| 4 | Medline | 33.00 Bn | 30.76 Bn | 1.84 Bn | - |
| 5 | Resmed | 29.47 Bn | 27.81 Bn | 890.98 Mn | - |
| 6 | West Pharmaceutical Services | 23.76 Bn | 23.32 Bn | 329.20 Mn | - |
| 7 | Solventum | 14.02 Bn | 13.46 Bn | 1.10 Bn | - |
| 8 | Cooper Companies | 13.89 Bn | 13.75 Bn | 735.40 Mn | - |
| 9 | Align Technology | 12.05 Bn | 10.99 Bn | 736.59 Mn | - |
| 10 | Biolife Solutions | 1.46 Bn | 1.38 Bn | 17.50 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -298,000.00 |
| Sep 30, 2024 | 52,000.00 |
| Mar 31, 2024 | 114,000.00 |
| Dec 31, 2023 | -236,000.00 |
| Jun 30, 2023 | 3,000.00 |